Eli Lilly partners with Walmart to sell weight-loss drug directly to patients nationwide

Patients will be able to access Eli Lilly's weight-loss drug Zepbound at Walmart pharmacies nationwide through its direct-to-consumer program as soon as next month. The partnership between Eli Lilly and Company and Walmart, announced Wednesday, will allow people with a valid prescription to pick up single-dose vials of Zepbound at Walmart pharmacies nationwide or opt for home delivery. Both are enabled through Eli Lilly's direct-to-consumer platform, LillyDirect. Lily's direct-to-consumer platform, which launched in early 2024, is the company's solution to improve the affordability and availab